KLRK1 and neoplasm: Guo et al. [68] designed chimeric PD1-NKG2D receptors containing the NKG2D hinge region and 4-1BB co-stimulatory domain, showed stable surface expression, and mediated the in vitro cytotoxicity of NK92 cells against various tumor cells.